Neuromodulation in Epilepsy Market Drivers, Restraints, Challenges & Competitive Landscape Global neuromodulation in epilepsy market was valued at US$ 1365.89 million in 2018 and is expected to reach US$ 3410.12 million by 2027, growing at an estimated CAGR of 10.71% over the forecast period. Some of the players operating in the neuromodulation in epilepsy market are Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroPace, Inc. amongst others.Download...
0 Geteilt
1999 Ansichten
0 Bewertungen